Dow Today: Pfizer (PFE) Leads The Day Higher, Coca-Cola (KO) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up five points at 17,111 as of Wednesday, Aug 27, 2014, 9:36 a.m. ET. During this time, 10 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 301 million. The NYSE advances/declines ratio sits at 1,592 issues advancing vs. 1,095 declining with 286 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Pfizer (NYSE: PFE), which is sporting a 28-cent gain (+1%) bringing the stock to $29.49. This single gain is lifting the Dow Jones Industrial Average by 2.12 points or roughly accounting for 42.4% of the Dow's overall gain. Volume for Pfizer currently sits at 1.5 million shares traded vs. an average daily trading volume of 23.3 million shares.

Pfizer has a market cap of $183.31 billion and is part of the health care sector and drugs industry. Shares are down 4.6% year-to-date as of Tuesday's close. The stock's dividend yield sits at 3.6%.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux